ABSTRACT:

Background: Hypertension is an important public-health problem, and it has been identified as the leading cause of morbidity and mortality due to the high incidence of end-organ damages. Unlike other complications of hypertension, cochlear dysfunction in hypertensive patients is a hidden and progressive damage that remains undetected (subclinical) for a long time. The aim of this study was to assess the prevalence of subclinical hearing impairment, as well as the type and degree of hearing loss among hypertensive patients in our environment.
Methods: This was a cross-sectional cohort study conducted among adults diagnosed with hypertension previously. Ethical clearance and informed consent were obtained. Previous history of related exposure event (hypertension) and outcome (hearing loss) was assessed. Each participant was then subjected to c-PTA and EHA tests, and findings were analyzed. 
Results: One hundred and ninety (190) hypertensive patients were enrolled, among which 107 (56.3%) were females and 83 (43.7%) males. Hypertension was more common in the age group of 51-60 years (26.8%) and 61-70 years (30.5%). The overall prevalence of hearing loss was 41.6%, of which 18.4% had subclinical hearing impairment. The most common type of hearing loss was sensorineural 68 (86.1%), found to be in varying degrees of 33.8%, 26.5%, 23.5%, and 16.2% for mild, moderate, severe, and profound hearing loss, respectively.
Conclusion: The overall prevalence of hearing loss among hypertensive patients was 41.6%, with a significant proportion (18.4%) having subclinical hearing loss, which is not noticed by the patients. Therefore, routine pure tone audiometric hearing screening for all hypertensives is recommended to enable early detection and treatment of this hearing loss.

KEYWORDS:

Hearing loss, Hypertension, Extended High Frequency Audiometry, Pure tone Audiometry, Prevalence, Subclinical hearing loss

REFERENCES :

1) Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–23.
2) Adeloye D, Basquill C. Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis. PLoS One 2014; 9:e104300.
3) Adeloye D, Basquill C, Aderemi AV, Thompson JY, Obi FA. An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis. J Hypertens. 2015; 33(2): 230–242.
4) WHO AFRO, editor. Report of regional director: cardiovascular diseases in the African region: current situation and perspectives. Regional committee for Africa; 17 June 2005. Maputo, Mozambique: The WHO Regional Office for Africa.
5) Sola AO, Chinyere OI, Stephen AO, Kayode JA. Hypertension prevalence in an Urban and Rural area of Nigeria. J Med Sci. 2013: 4(4); 149–154.
6) Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJC, Falase AO, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: a review World J Cardiol. 2012; 4:327–340.
7) Kirbac A, Boke B. Effects of primary arterial hypertension on cochlear function. Acta Otolaryngol. 2021; 141(2):158-162.
8) Soares MA, Sanches SG, Matas CG, Samelli AG. The audiological profile of adults with and without hypertension. Clinics (Sao Paulo). 2016; 71(4):187–192.
9) World Health Organization. Deafness and hearing loss. Geneva: WHO; 2021. www.who.int/news-room/fact-sheets/details/deafness-and-hearing-loss. [Accessed 14 February 2022]
10) Adamu A, Ogunleye OO, Kirfi AM, Ballah AM, Bwala KJ, Abdull MM et al. Relationship Between Some Cardiovascular Risk Factors (Hypertension and Diabetes) and Hearing Loss: A Review and Critical Appraisal. International Journal of Medical Science and Clinical Research Studies. 2024 Jun 21;4(06):1221-5.
11) Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ 2014; 92:367–373.
12) Adamu A, Ajiya A, Abdullahi H, Hasheem MG, Bello-Muhammad N. Adherence to protective measures against hearing related hazards of mobile phone users among university students. Niger J Med 2020;29(2):312-6.
13) Adamu A, Mohammed A, Mohammed N, Bulama H, Shehu Y, Garbati M, et al. Pure Tone Audiometric Evaluation of Hearing Loss among Diabetic Patients in Azare: A Prospective Observational Study. International Journal of Medical Science and Clinical Research Studies. 2024; 4(7): 1390-1395. https://doi.org/10.47191/ijmscrs/v4-i07-21
14) Yu KK, Choi CH, An YH, Kwak MY, Gong SJ, Yoon SW, Shim HJ. Comparison of the effectiveness of monitoring cisplatin-induced ototoxicity with extended high-frequency pure-tone audiometry or distortion-product otoacoustic emission. Korean journal of audiology. 2014;18(2):58.
15) Jibril YN, Adamu A, Jalo RI, Farouk ZL, Salisu AD, B. Nwaorgu OG. Transient-evoked otoacoustic emission findings in children (1–12 years) with cerebral palsy in Kano, Nigeria. Nigerian Postgradraduate Medical Journal. 2020;27(4):371-6.
16) Jibril YN, Shamsu KA, Adamu A, Abdullahi H, Kolo ES, Ahmed SG. Assessment of cochlear function in children with sickle cell anemia. Indian Journal of Otology. 2021;27(4):203-8.
17) Balatsouras DG, Homsioglou E, Danielidis V. Extended high‐frequency audiometry in patients with acoustic trauma. Clinical Otolaryngology. 2005;30(3):249-54.
18) Gibrin PC, Melo JJ, Marchiori LD. Prevalence of tinnitus complaints and probable association with hearing loss, diabetes mellitus and hypertension in elderly. InCoDAS. 2013; 25(2):176-80.
19) Beevers G, Lip GY, O’Brien E. Blood pressure measurement: Part II—Conventional sphygmomanometry: Technique of auscultatory blood pressure measurement. BMJ. 2001; 28;322(7293):1043-7.
20) Genevieve M Gabb, Arduino A Mangoni, Craig S Anderson, Diane Cowley, John S Dowden, et al. Guideline for the diagnosis and management of hypertension in adults-2016. Med J Aust 205: 85-89.
21) Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-72.
22) International Organization for Standardization. Acoustics Audiometric Test Methods- Part 1: Basic Pure-Tone air and Bone Conduction Threshold Audiometry. ISO 8253-1:2010. Geneva, Switzerland: ISO
23) Poling GL, Kunnel TJ, Dhar S. Comparing the accuracy and speed of manual and tracking methods of measuring hearing thresholds. Ear and hearing. 2016;37(5):e336.
24) World Health Organization. Prevention of Blindness and Deafness: Grades of Hearing Impairment. Geneva: World Health Organization. 2014. http://who.int/pbd/deafness/hearing_impairment_grades/en. (Accessed 12 February 2022).
25) Wallhagen MI. The stigma of hearing loss. The Gerontologist. 2010;50(1):66-75.
26) Word Health Organization. Addressing the rising prevalence of hearing loss. Geneva: World Health Organization. 2018. http://apps.who.int/iris. (Accessed 20 February 2022).
27) Chadha S, Kamenov K, Cieza A. The world report on hearing, 2021. Bulletin of the World Health Organization. 2021 Apr 1;99(4):242.
28) Osuji AE, Da Lilly-Tariah OB, Unachukwu CN, Nwankwo BE. Comparison of Hearing Threshold in H ypertensive and Non Hypertensive Type 2 DM. J Otorhinolaryngol Disord Treat. 2020;1(1): 1-7.
29) Yikawe SS, Uguru SU, Solomon JH, Adamu AM, Damtong F, Osisi K, et al. Hearing loss among hypertensive patients. Egypt J Otolaryngol. 2019; 35:307–312.
30) Quadri OR, Gbujie IO, Ojji DB, Folorunso DF, Damtong FM, Dahilo EA, et al. Sensorineural hearing loss among hypertensives. West Afr J Med. (2021) 38:125–30.
31) Ramatsoma H, Patrick SM. Hypertension associated with hearing loss and tinnitus among hypertensive adults at a tertiary hospital in South Africa. Frontiers in neurology. 2022 Mar 16;13:857600.
32) Babarinde JA, Adeyemo AA, Adeoye AM. Hearing loss and hypertension: exploring the linkage. The Egyptian Journal of Otolaryngology. 2021;37(1):1-6.
33) Agarwal S, Mishra A, Jagade M, Kasbekar V, Nagle SK. Effects of hypertension on hearing. Indian J Otolaryngol Head Neck Surg 2013; 65:614–618.